Home Stocks Alkem Laboratories Ltd

Alkem Laboratories Ltd

The live share price of Alkem Laboratories Ltd (ALKEM) as on 08 Dec 10:10am is ₹4,796.05 from NSE/BSE.

ALKEM NSE

₹4,796.05 ▼-1.91% (-93.45)

As on Dec 08, 2023 03:40 PM IST

How do you feel today about Alkem Laboratories Ltd?

Bearish or

Bullish

Bearish or

Bullish

Key Metrics

PE Ratio

40.8

PB Ratio

6.2

Dividend Yield

1.02%

Sector PB

5.11

Sector PE

44.48

Sector Div Yld

0.7%

Dividend Yield

Dividend per share for the most recent financial year divided by the close price

About

Sector

Health Care

Industry

Pharmaceuticals

Market Cap

Midcap, ₹58,461 Cr

Alkem Laboratories Limited is engaged in the development, manufacture and sale of pharmaceutical and neutraceutical products.

The following charts display the financial performance of the Alkem Laboratories Ltd (ALKEM) stock, including the year-on-year Income Statement , Balance Sheet , Cash Flow Statement and Shareholding pattern.

Furthermore, under the Peers section, you can find stocks that are similar to Alkem Laboratories Ltd (ALKEM), and their live stock price and performance at a glance. Click on any peer stock to navigate to that stock’s live price page.

✅ If you’re new to investing in the stock market, and/or are unsure about your investment options, you can explore smallcases.

A smallcase is a readymade stock/ETF portfolio (also known as a stock basket) that is based on an investment idea, theme or strategy. Examples of popular smallcases include All Weather Investing , Equity and Gold , Top 100 Stocks , Green Energy and Value & Momentum.

All smallcases are created and managed by SEBI-registered investment experts.

To invest in smallcases, all you need is a demat/trading account. You retain complete ownership of the smallcase’s constituent stocks or ETFs, as they are directly credited to your broking account. You can choose from over 500+ smallcases across 180+ smallcase managers to start your investment journey.

Sector

Health Care

Industry

Pharmaceuticals

Market Cap

Midcap, ₹58,461 Cr

Financials

Income Statement

(INR)		Y/Y Change
Revenue	11,815 Cr	+9.43%
Operating Expense	1,189 Cr	+3549.34%
Net Income	984 Cr	-40.19%
Net Profit Margin	8.33%	-45.34%
Earning Per Share	82	-40.2%
EBITDA	1,722 Cr	-21.72%

Balance sheet

(INR)		Y/Y Change
Cash & short-term Inv	2,934 Cr	+7.96%
Total Assets	13,756 Cr	-2.22%
Total Liabilities	4,321 Cr	-17.24%
Total Equity	9,435 Cr	+6.64%
Shares Outstanding	11.96 Cr	+0.03%
Price to Book	4.3	-8.91%
Return on Assets	7.07%	-45.02%
Return on Capital	14.97 Cr	-30.18%

Cash Flows

(INR)		Y/Y Change
Net Income	984 Cr	-40.19%
Cash from Operations	1,682 Cr	+51.44%
Cash from Investing	119 Cr	-108.37%
Cash from Financing	-1,760 Cr	-563.9%
Net Change in Cash	41 Cr	-28.19%
Free Cash Flow	1,449 Cr	+87.74%

Shareholding Pattern

Total Promoter Holding

56.74%

Unpledged

Foreign Institutions

6.03%

Foreign Institutions

Retail & Others

19.59%

Retail & Others

Other Parties

Other Domestic Institutions

4.58%

Insurance Firms

Others

Mutual Funds

13.05%

Mutual Funds

Peers

SUNPHARMA

Sun Pharmaceutical Industries Ltd

PE Ratio

34.78

1Y Return

▲26%

CIPLA

Cipla Ltd

PE Ratio

28.59

1Y Return

▲10.08%

DRREDDY

Dr Reddy's Laboratories Ltd

PE Ratio

18.92

1Y Return

▲32.31%

MANKIND

Mankind Pharma Ltd

PE Ratio

51.24

1Y Return

▲37.3%

Latest News

Trade setup for Wednesday: 15 things to know before opening bell

4 weeks ago on Moneycontrol

Change since news ▼-11.37%

Based on the OI percentage, 61 stocks saw long unwinding, including Chambal Fertilisers and Chemicals, Alkem Laboratories, Balkrishna Industries, Metropolis Healthcare, and United Spirits

Hot Stocks | Expect healthy double-digit return in Alkem Laboratories, JK Lakshmi Cement, Torrent Pharma in short term

4 weeks ago on Moneycontrol

Change since news ▼-11.99%

The outlook for the Nifty Index leans towards a neutral scenario. There is an expectation of further rangebound movement in the Nifty, potentially between 18,830 – 19,560 levels.

Trade Spotlight: What should you do with Poonawalla Fincorp, HPCL, Alkem Laboratories today?

1 month ago on Moneycontrol

Change since news ▼-13.31%

Poonawalla Fincorp continued its healthy uptrend for yet another session, and formed robust bullish candlestick pattern on the daily charts, with strong volumes, after breaking out falling resistance trendline.

FAQs on Alkem Laboratories Ltd

How to buy Alkem Laboratories Ltd stocks?

You can easily buy the stocks/shares of Alkem Laboratories Ltd (ALKEM) through either a broker or a financial institution by opening a Demat & Trading account online via smallcase.

What is the Share Price of Alkem Laboratories Ltd?

The stock price of Alkem Laboratories Ltd as on 08 Dec 2023 is ₹4,796.05

What is the 52-week High and Low of Alkem Laboratories Ltd?

The 52-week high and low of Alkem Laboratories Ltd (ALKEM) is ₹4,900 and ₹2,940.05.

What is the PE and PB ratio of Alkem Laboratories Ltd?

The P/E (price-to-earnings) and P/B (price-to-book) ratios of Alkem Laboratories Ltd are 40.8 and 6.2 respectively.

What are the peers or stocks similar to Alkem Laboratories Ltd?

The peers or stocks similar to Alkem Laboratories Ltd are Sun Pharmaceutical Industries Ltd, Cipla Ltd, Dr Reddy's Laboratories Ltd, Mankind Pharma Ltd and many others. smallcase also offers over 200 readymade stock baskets managed by 180+ SEBI-registered investment experts. These stock portfolios are based on a theme, idea or strategy. You can use smallcase to start investing in diversified stock baskets.

Which sector does Alkem Laboratories Ltd belong to?

Alkem Laboratories Ltd (ALKEM) belongs to the Pharmaceuticals sector.

What is the Market Cap of Alkem Laboratories Ltd?

Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Alkem Laboratories Ltd (ALKEM) is ₹58,461 Cr as of 08 Dec 2023

Can't decide whether or not to buy Alkem Laboratories Ltd stocks? ⭐️

Worry no more! smallcase offers readymade stock baskets/portfolios that are based on an theme, idea or strategy. You can choose from more than 500+ stock portfolios managed by 180+ SEBI-registered investment experts.

Dislaimer: This platform is intended for informational purposes only and is not intended to provide investment advice. The stock prices displayed are delayed and may not reflect the most current market conditions. Investment in securities market are subject to market risks. Read all the related documents carefully before investing. You can also consider consulting a financial advisor before making any investment decisions. Smallcase Technologies Private Limited shall not be responsible for any losses that may occur as a result of using this platform.